Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells.

Back

ESC Professional Premium Access

Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells.

Session: Ischaemia reperfusion

Topic: Ischaemia, Infarction, Cardioprotection

Speaker: Doctor P. Nikolaou (Athens, GR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Panagiota Efstathia Nikolaou

National & Kapodistrian University of Athens, Athens (Greece)

1 follower

7 more presentations in this session

Platelet-derived microRNAs play a pivotal role in cardiac remodeling after myocardial ischemia and reperfusion

Speaker: Mr J. Schuette (Tuebingen, DE)

Mitochondrial succinate transport as a novel therapeutic target for cardiac ischemia/reperfusion injury

Speaker: Doctor H. Prag (Cambridge, GB)

Discovery and in vivo evaluation of novel inhibitors of the hydrolytic activity of mitochondrial F1Fo ATP synthase to alleviate myocardial ischemia reperfusion injury

Speaker: Doctor P. Nikolaou (Athens, GR)

Conditional knock out of cytosolic thioredoxin (Trx) in cardiomyocytes impairs cardiac function and exacerbates ischemia-reperfusion injury

Speaker: Professor K. Das (Lubbock, US)

Temporal proteomic and phosphoproteomic profiling of the left ventricle in a novel rat model of ischemia/reperfusion with or without ischemic preconditioning

Speaker: Doctor S. Hussain (Gothenburg, SE)

Access the full session

Ischaemia reperfusion

Speakers: Doctor P. Nikolaou, Mr J. Schuette, Doctor H. Prag, Doctor P. Nikolaou, Professor K. Das...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources